Original Article| Volume 23, ISSUE 6, P1374-1384, July 2014

Prospective Registry of Carotid Artery Stenting in Japan—Investigation on Device and Antiplatelet for Carotid Artery Stenting


      Carotid artery stenting (CAS) is minimally invasive but may cause perioperative cerebral infarction associated with distal embolization. We conducted a multicenter prospective observational study on the onset of vascular events after CAS to find out the efficacy and safety of CAS in Japan and to investigate the effects of antiplatelet drugs administered before and after CAS on efficacy and safety of CAS.


      A total of 949 patients with cervical carotid artery stenosis were enrolled at 43 institutions in Japan; 934 who had undergone CAS with antiplatelet drugs and followed for 1 year were analyzed. Primary end point was the incidence of the first event of death, ischemic stroke, hemorrhagic stroke, transient ischemic attack, myocardial infarction, or serious hemorrhage within 1 year after enrollment. Comparison of the incidences of events according to antiplatelet drugs was also conducted.


      The primary end point was observed in 69 patients (7.4%) within 30 days of enrollment and in 40 patients (4.3%) between 31 days and 1 year after enrollment. The incidence of the first event for aspirin + cilostazol was significantly lower than that for aspirin + clopidogrel (P = .01), aspirin + clopidogrel + cilostazol (P = .01), and antiplatelet monotherapy (P < .01). Patient age (P = .01), presence of ischemic cerebrovascular disease (P = .02), presence of antidiabetic drugs (P < .01), femoral artery puncture (P = .02), guiding catheter used (P = .02), and Angioguard XP used (P = .01) were also correlated with the primary end point.


      Incidences of the primary end point within 30 days and 1 year of enrollment were comparable with previous reports, suggesting that CAS is a useful alternative for carotid endarterectomy in carotid stenosis patients with high risk for carotid endarterectomy. Further randomized controlled studies are needed to determine whether differences in mechanism of action of antiplatelet drugs might have contributed to the results of the present study.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Stroke and Cerebrovascular Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • North American Symptomatic Carotid Endarterectomy Trial Collaborators
        Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis.
        N Engl J Med. 1991; 325: 445-453
        • Yadav J.S.
        • Wholey M.H.
        • Kuntz R.E.
        • et al.
        • Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy Investigators
        Protected carotid-artery stenting versus endarterectomy in high-risk patients.
        N Engl J Med. 2004; 351: 1493-1501
        • Brott T.G.
        • Halperin J.L.
        • Abbara S.
        • et al.
        2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery Developed in Collaboration With the American Academy of Neurology and Society of Cardiovascular Computed Tomography.
        J Am Coll Cardiol. 2011; 57: 1002-1044
      1. Japanese guidelines for the management of stroke.
        Japan Stroke Society. 2009; ([in Japanese])
        • Toyoda A.
        • Shima T.
        • Nishida M.
        • et al.
        Angiographical evaluation of extracranial carotid artery comparison between Japanese and Hungarian.
        Brain Nerve. 1997; 49 ([in Japanese]): 633-637
      2. Report on training for medical institutions by the Japan Neurosurgical Society [in Japanese]. Japan Neurological Society, 2011, unpublished.

        • Mas J.L.
        • Chatellier G.
        • Beyssen B.
        • et al.
        • EVA-3S Investigators
        Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis.
        N Engl J Med. 2006; 19: 1660-1671
        • Ederle J.
        • Dobson J.
        • et al.
        • International Carotid Stenting Study investigators
        Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial.
        Lancet. 2010; 375: 985-997
        • Ringleb P.A.
        • Allenberg J.
        • et al.
        • SPACE Collaborative Group
        30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial.
        Lancet. 2006; 368: 1239-1247
        • Brott T.G.
        • Hobson II, R.W.
        • Howard G.
        • et al.
        Stenting versus endarterectomy for treatment of carotid-artery stenosis.
        N Engl J Med. 2010; 363: 11-23
        • Miyachi S.
        • Taki W.
        • Sakai
        • et al.
        Historical perspective of carotid artery stenting in Japan: analysis of 8,092 cases in The Japanese CAS Survey.
        Acta Neurochir (Wien). 2012; 154: 2127-2137
        • Tanaka K.
        • Gotoh F.
        • Fukuuchi Y.
        • et al.
        Effects of a selective inhibitor of cyclic AMP phosphodiesterase on the pial microcirculation in feline cerebral ischemia.
        Stroke. 1989; 20: 668-673